Trial intelligence / Profile preview

Comparison of Pra-Sa-Prao-Hyai powder and loratadine in allergic rhinitis

TCTR20201003003Phase 2Completed

Sponsor
Faculty of Medicine, Thammasat University
Start
Aug 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of loratadine in allergic rhinitis (AR), sponsored by Faculty of Medicine, Thammasat University. Started Aug 2014; status: completed.

02

Drugs

loratadine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on TCTR20201003003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201003003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call